ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+7.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$111M
AUM Growth
+$33.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
58
New
Increased
Reduced
Closed

Top Buys

1
+$12.1M
2
+$7.38M
3
+$6.46M
4
AVTR icon
Avantor
AVTR
+$4.83M
5
CNMD icon
CONMED
CNMD
+$4.82M

Top Sells

1
+$7.86M
2
+$5.63M
3
+$5.5M
4
BDX icon
Becton Dickinson
BDX
+$3.53M
5
IQV icon
IQVIA
IQV
+$3.31M

Sector Composition

1 Healthcare 94.79%
2 Real Estate 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PODD icon
26
Insulet
PODD
$12.1B
$1.42M 1.27%
+8,878
ETNB
27
DELISTED
89bio
ETNB
$1.27M 1.14%
82,153
+52,871
HOLX
28
DELISTED
Hologic
HOLX
$1.23M 1.11%
+17,750
OCUL icon
29
Ocular Therapeutix
OCUL
$2.05B
$1.11M 1%
353,707
-14,731
AZTA icon
30
Azenta
AZTA
$1.15B
$975K 0.88%
+19,422
TARS icon
31
Tarsus Pharmaceuticals
TARS
$2.74B
$847K 0.76%
+47,649
AHCO icon
32
AdaptHealth
AHCO
$1.79B
$818K 0.74%
+89,937
AXSM icon
33
Axsome Therapeutics
AXSM
$10.6B
$787K 0.71%
+11,254
IQV icon
34
IQVIA
IQV
$26.5B
$776K 0.7%
3,946
-15,223
BLUE
35
DELISTED
bluebird bio
BLUE
$765K 0.69%
12,589
-1,483
OLMA icon
36
Olema Pharmaceuticals
OLMA
$1.25B
$723K 0.65%
58,573
+18,389
VTYX
37
DELISTED
Ventyx Biosciences
VTYX
$641K 0.58%
+18,458
ACLX
38
DELISTED
Arcellx
ACLX
$508K 0.46%
+14,158
GDRX icon
39
GoodRx Holdings
GDRX
$864M
$491K 0.44%
+87,290
RNAC icon
40
Cartesian Therapeutics
RNAC
$182M
$481K 0.43%
15,110
-7,761
TLT icon
41
iShares 20+ Year Treasury Bond ETF
TLT
$42.2B
$302K 0.27%
+3,400
NVST icon
42
Envista
NVST
$4.29B
$301K 0.27%
+10,787
ADAP
43
DELISTED
Adaptimmune Therapeutics
ADAP
$243K 0.22%
311,944
-509,094
EHC icon
44
Encompass Health
EHC
$10.7B
– –
-32,710
LH icon
45
Labcorp
LH
$21.1B
– –
-37,910
A icon
46
Agilent Technologies
A
$32.4B
– –
-45,762
ACHC icon
47
Acadia Healthcare
ACHC
$2.56B
– –
-9,153
SPY icon
48
State Street SPDR S&P 500 ETF Trust
SPY
$736B
– –
0
BDX icon
49
Becton Dickinson
BDX
$42.5B
– –
-13,360
BTAI icon
50
BioXcel Therapeutics
BTAI
$32.5M
– –
0
1
2
3